Global Self Monitoring Blood Glucose (SMBG) Device Supply, Demand and Key Producers, 2023-2029

Global Self Monitoring Blood Glucose (SMBG) Device Supply, Demand and Key Producers, 2023-2029

The global Self Monitoring Blood Glucose (SMBG) Device market size is expected to reach $ 24590 million by 2029, rising at a market growth of 8.8% CAGR during the forecast period (2023-2029).

Self-monitoring blood glucose (SMBG) device refers to portable instruments that can identify the possibilities of diabetes. These devices usually measure glucose levels by obtaining a small drop of blood from patients by pricking their fingers. International guidelines recommend this method for managing a patient’s diabetes successfully. The self-monitoring blood glucose (SMBG) device are used to measure the concentration of glucose in the blood.

This report studies the global Self Monitoring Blood Glucose (SMBG) Device production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Self Monitoring Blood Glucose (SMBG) Device, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Self Monitoring Blood Glucose (SMBG) Device that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Self Monitoring Blood Glucose (SMBG) Device total production and demand, 2018-2029, (K Units)

Global Self Monitoring Blood Glucose (SMBG) Device total production value, 2018-2029, (USD Million)

Global Self Monitoring Blood Glucose (SMBG) Device production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Self Monitoring Blood Glucose (SMBG) Device consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Self Monitoring Blood Glucose (SMBG) Device domestic production, consumption, key domestic manufacturers and share

Global Self Monitoring Blood Glucose (SMBG) Device production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Self Monitoring Blood Glucose (SMBG) Device production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Self Monitoring Blood Glucose (SMBG) Device production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Self Monitoring Blood Glucose (SMBG) Device market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Bionime Corporation, B.Braun Melsungen AG, F.Hoffmann-La Roche Ltd., LifeScan Inc., PHC Holdings Corporation, Home Diagnostics Inc., Terumo Pharmaceutical Solutions and ARKRAY Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Self Monitoring Blood Glucose (SMBG) Device market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Self Monitoring Blood Glucose (SMBG) Device Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Self Monitoring Blood Glucose (SMBG) Device Market, Segmentation by Type
Self-Monitoring Blood Glucose Meters
Continuous Glucose Monitors
Testing Strips
Lancets

Global Self Monitoring Blood Glucose (SMBG) Device Market, Segmentation by Application
Hospital Pharmacy
Retail Pharmacy
Diabetes Clinic

Companies Profiled:
Abbott Laboratories
Bionime Corporation
B.Braun Melsungen AG
F.Hoffmann-La Roche Ltd.
LifeScan Inc.
PHC Holdings Corporation
Home Diagnostics Inc.
Terumo Pharmaceutical Solutions
ARKRAY Inc.
Ypsomed Holding AG
Dexcom Inc.
Medtronic PLC.
Novo Nordisk
Glysens Incorporated
Senseonics Holdings
Ascensia

Key Questions Answered

1. How big is the global Self Monitoring Blood Glucose (SMBG) Device market?

2. What is the demand of the global Self Monitoring Blood Glucose (SMBG) Device market?

3. What is the year over year growth of the global Self Monitoring Blood Glucose (SMBG) Device market?

4. What is the production and production value of the global Self Monitoring Blood Glucose (SMBG) Device market?

5. Who are the key producers in the global Self Monitoring Blood Glucose (SMBG) Device market?

6. What are the growth factors driving the market demand?